Integrating machine learning and multi-omics analysis to identify and validate key genes associated with periodontitis
DOI:
https://doi.org/10.2340/aos.v85.46662Keywords:
Multi-omics, machine learning, Mendelian randomization, biomarker, periodontitisAbstract
Aims: Early detection and intervention are crucial for effective management of periodontitis. Our study aims to identify diagnostic biomarkers for periodontitis by integrating single-cell RNA sequencing analysis, Mendelian randomization, and experimental validation.
Methods: Gene Expression Omnibus (GEO) dataset GSE164241 was downloaded to analyze the cellular compositions and intercellular communications in periodontitis.
GEO datasets GSE10334, GSE16134, GSE23586, and GSE106090 were downloaded, and differential expression genes (DEGs) and functional enrichment were analyzed, followed by investigation of endothelial-fibroblast signaling pathways. Molecular subtypes were defined based on myeloid and fibroblast markers, and their immune characteristics were analyzed. A diagnostic model was built using 106 algorithm combinations from 11 machine learning methods (Lasso, Ridge, Enet, Stepglm, SVM, glmBoost, LDA, RandomForest, GBM, XGBoost, and NaiveBayes) to screen reliable biomarkers. Key genes were identified using Mendelian randomization and validated via reverse transcription and quantitative polymerase chain reaction (RT-qPCR).
Results: This study identified four novel periodontitis subtypes using consensus clustering based on myeloid cell and fibroblast markers: fibroblast-dominant, myeloid-dominant, fibroblast/myeloid quiescent, and fibroblast/myeloid mixed. These four subtypes exhibited unique biological patterns, potentially leading to different disease progression. Patients in the fibroblast/myeloid mixed and myeloid-dominant groups, in particular, may have a stronger inflammatory microenvironment. In addition, we found that IGFBP4, IL1B, LAPTM5, PSAP, and SRGN were closely related to the occurrence and development of periodontitis through random forest (RF) analysis and Mendelian randomization. RT-qPCR validation in gingival tissues from 13 stage III/IV periodontitis patients and healthy controls confirmed significant differences in the expression of IGFBP4, IL1B, and LAPTM5 (p < 0.001).
Conclusion: Our findings suggest that IGFBP4, IL1B, and LAPTM5 could be potential biomarkers for periodontitis, paving the way for future research on its pathogenesis, diagnosis, and treatment.
Downloads
References
Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. DOI: https://doi.org/10.1038/nrdp.2017.38
Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000. 2013;62(1):203–17. DOI: https://doi.org/10.1111/j.1600-0757.2012.00450.x
Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990–2010: a systematic review and meta-regression. J Dent Res. 2014;93(11):1045–53. DOI: https://doi.org/10.1177/0022034514552491
Pattamatta M, Chapple I, Listl S. The value-for money of preventing and managing periodontitis: Opportunities and challenges. Periodontol 2000. 2025 Jun;98(1):56-64. DOI: https://doi.org/10.1111/prd.12569
Natto ZS, Abu Ahmad RH, Alsharif LT, et al. Chronic periodontitis case definitions and confounders in periodontal research: a systematic assessment. Biomed Res Int. 2018;2018:4578782. DOI: https://doi.org/10.1155/2018/4578782
Gürsoy UK, Özdemir Kabalak M, Gürsoy M. Advances in periodontal biomarkers. Adv Clin Chem. 2024;120:145–68. DOI: https://doi.org/10.1016/bs.acc.2024.03.003
Lähnemann D, Köster J, Szczurek E, et al. Eleven grand challenges in single-cell data science. Genome Biol. 2020;21(1):31. DOI: https://doi.org/10.1186/s13059-020-1926-6
Stuart T, Satija R. Integrative single-cell analysis. Nat Rev Genet. 2019;20(5):257–72. DOI: https://doi.org/10.1038/s41576-019-0093-7
Zhang X, Lan Y, Xu J, et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721–8. DOI: https://doi.org/10.1093/nar/gky900
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–20. DOI: https://doi.org/10.1016/S0140-6736(05)67728-8
Kebschull M, Demmer RT, Papapanou PN. ‘Gum bug, leave my heart alone!’ – epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res. 2010;89(9):879–902. DOI: https://doi.org/10.1177/0022034510375281
Kiselev VY, Andrews TS, Hemberg M. Challenges in unsupervised clustering of single-cell RNA-seq data. Nat Rev Genet. 2019;20(5):273–82. DOI: https://doi.org/10.1038/s41576-018-0088-9
Silva LM, Brenchley L, Moutsopoulos NM. Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis. Immunol Rev. 2019;287(1):226–35. DOI: https://doi.org/10.1111/imr.12724
Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. DOI: https://doi.org/10.1186/s13059-016-1070-5
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7. DOI: https://doi.org/10.1038/nmeth.3337
Liu Z, Liu L, Weng S, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. DOI: https://doi.org/10.1038/s41467-022-28421-6
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–98. DOI: https://doi.org/10.1093/hmg/ddu328
Lu R, Meng H, Gao X, Xu L, Feng X. Effect of non-surgical periodontal treatment on short chain fatty acid levels in gingival crevicular fluid of patients with generalized aggressive periodontitis. J Periodontal Res. 2014;49(5):574–83. DOI: https://doi.org/10.1111/jre.12137
Qiqiang L, Huanxin M, Xuejun G. Longitudinal study of volatile fatty acids in the gingival crevicular fluid of patients with periodontitis before and after nonsurgical therapy. J Periodontal Res. 2012;47(6):740–9. DOI: https://doi.org/10.1111/j.1600-0765.2012.01489.x
Zhang D, Xu T, Xu Q, et al. Expression profile of macrophage migration inhibitory factor in periodontitis. Arch Oral Biol. 2021;122:105003. DOI: https://doi.org/10.1016/j.archoralbio.2020.105003
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Clin Periodontol. 2018;45(Suppl 20):S149–61. DOI: https://doi.org/10.1111/jcpe.12945
Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(8 Suppl):1569–76. DOI: https://doi.org/10.1902/jop.2008.080233
Abel AM, Yang C, Thakar MS, Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front Immunol. 2018;9:1869. DOI: https://doi.org/10.3389/fimmu.2018.01869
Abdulkareem AA, Al-Taweel FB, Al-Sharqi AJB, Gul SS, Sha A, Chapple ILC. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023;15(1):2197779. DOI: https://doi.org/10.1080/20002297.2023.2197779
Bertl K, Tangl S, Rybaczek T, et al. Prevalence and severity of periodontal disease in a historical Austrian population. J Periodontal Res. 2020;55(6):931–45. DOI: https://doi.org/10.1111/jre.12785
Könönen E, Gursoy M, Gursoy UK. Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med. 2019 Jul 31;8(8):1135. DOI: https://doi.org/10.3390/jcm8081135
Tonetti MS, Van Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(Suppl 14):S24–9. DOI: https://doi.org/10.1111/jcpe.12089
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44. DOI: https://doi.org/10.1038/nri3785
Sanz M, Kornman K. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol. 2013;84(4 Suppl):S164–9. DOI: https://doi.org/10.1902/jop.2013.1340016
Zheng GX, Terry JM, Belgrader P, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049. DOI: https://doi.org/10.1038/ncomms14049
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–50. DOI: https://doi.org/10.1146/annurev.immunol.021908.132612
Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117(14):3720–32. DOI: https://doi.org/10.1182/blood-2010-07-273417
Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8–27. DOI: https://doi.org/10.1111/imr.12621
Ruscitti P, Cipriani P, Carubbi F, et al. The role of IL-1β in the bone loss during rheumatic diseases. Mediators Inflamm. 2015;2015:782382. DOI: https://doi.org/10.1155/2015/782382
Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–38. DOI: https://doi.org/10.1016/j.jacc.2009.09.009
Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003;74(3):391–401. DOI: https://doi.org/10.1902/jop.2003.74.3.391
Hasan A, Palmer RM. A clinical guide to periodontology: pathology of periodontal disease. Br Dent J. 2014;216(8):457–61. DOI: https://doi.org/10.1038/sj.bdj.2014.299
Ramadan DE, Hariyani N, Indrawati R, Ridwan RD, Diyatri I. Cytokines and chemokines in periodontitis. Eur J Dent. 2020;14(3):483–95. DOI: https://doi.org/10.1055/s-0040-1712718
Dagenais M, Skeldon A, Saleh M. The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death Differ. 2012;19(1):5–12. DOI: https://doi.org/10.1038/cdd.2011.159
Abdul-Sater AA, Saïd-Sadier N, Ojcius DM, Yilmaz O, Kelly KA. Inflammasomes bridge signaling between pathogen identification and the immune response. Drugs Today (Barc). 2009;45(Suppl B):105–12.
García-Hernández AL, Muñoz-Saavedra Á E, González-Alva P, et al. Upregulation of proteins of the NLRP3 inflammasome in patients with periodontitis and uncontrolled type 2 diabetes. Oral Dis. 2019;25(2):596–608. DOI: https://doi.org/10.1111/odi.13003
Isaza-Guzmán DM, Medina-Piedrahíta VM, Gutiérrez-Henao C, Tobón-Arroyave SI. Salivary levels of NLRP3 inflammasome-related proteins as potential biomarkers of periodontal clinical status. J Periodontol. 2017;88(12):1329–38. DOI: https://doi.org/10.1902/jop.2017.170244
Zhao D, Wu Y, Zhuang J, Xu C, Zhang F. Activation of NLRP1 and NLRP3 inflammasomes contributed to cyclic stretch-induced pyroptosis and release of IL-1β in human periodontal ligament cells. Oncotarget. 2016;7(42):68292–302. DOI: https://doi.org/10.18632/oncotarget.11944
Rocha FRG, Delitto AE, de Souza JAC, Maldonado LAG, Wallet SM, Rossa C, Jr. NLRC4 inflammasome has a protective role on inflammatory bone resorption in a murine model of periodontal disease. Immunobiology. 2020;225(1):151855. DOI: https://doi.org/10.1016/j.imbio.2019.10.004
Park E, Na HS, Song YR, Shin SY, Kim YM, Chung J. Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection. Infect Immun. 2014;82(1):112–23. DOI: https://doi.org/10.1128/IAI.00862-13
Wang S, Chi K, Wu D, Hong Q. Insulin-like growth factor binding proteins in kidney disease. Front Pharmacol. 2021;12:807119. DOI: https://doi.org/10.3389/fphar.2021.807119
Baxter RC. IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer. 2014;14(5):329–41. DOI: https://doi.org/10.1038/nrc3720
Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab. 1996;81(1):150–5. DOI: https://doi.org/10.1210/jcem.81.1.8550744
Götz W, Lossdörfer S, Krüger U, Braumann B, Jäger A. Immunohistochemical localization of insulin-ike growth factor-II and its binding protein-6 in human epithelial cells of Malassez. Eur J Oral Sci. 2003;111(1):26–33. DOI: https://doi.org/10.1034/j.1600-0722.2003.00003.x
Götz W, Heinen M, Lossdörfer S, Jäger A. Immunohistochemical localization of components of the nsulin-like growth factor system in human permanent teeth. Arch Oral Biol. 2006;51(5):387–95. DOI: https://doi.org/10.1016/j.archoralbio.2005.10.005
Zhang MM, Liang MJ, Zhang DM, et al. The function and mechanism of LAPTM5 in diseases. Biomed Pharmacother. 2024;178:117237. DOI: https://doi.org/10.1016/j.biopha.2024.117237
Xing L, Li Y, Li W, et al. Expression of RUNX2/LAPTM5 in the induction of MC3T3-e1 mineralization and ts possible relationship with autophagy. Tissue Eng Regen Med. 2022;19(6):1223–35. DOI: https://doi.org/10.1007/s13770-022-00477-x
Geng YM, Liu CX, Lu WY, et al. LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells. Mol Med Rep. 2019;20(5):4193–201. DOI: https://doi.org/10.3892/mmr.2019.10688
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 Yierfan Nuermaimaiti, Reyila Jureti, Aierpati Maimaiti, Yiming Li, Gulinuer Awuti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Odontologica Scandinavica publishes high quality original research papers as well as critical reviews relevant on diseases of the oral cavity, their treatment, epidemiology and associated biomaterials and their development.
